Status: current, Primitive. Date: 31-Jan 2015. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3012148012 | Pertuzumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3012447013 | Pertuzumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pertuzumab | Is a | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
| Pertuzumab | Has disposition | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
| Pertuzumab | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Pertuzumab | Is a | Enzyme inhibitor protein | true | Inferred relationship | Some | ||
| Pertuzumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Pertuzumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pertuzumab only product | Has active ingredient | True | Pertuzumab | Inferred relationship | Some | 1 |
| Pertuzumab-containing product in parenteral dose form | Has active ingredient | True | Pertuzumab | Inferred relationship | Some | 1 |
| Pertuzumab only product in parenteral dose form | Has active ingredient | True | Pertuzumab | Inferred relationship | Some | 1 |
| Pertuzumab 30mg/mL solution for injection | Has active ingredient | False | Pertuzumab | Inferred relationship | Some | |
| Pertuzumab-containing product | Has active ingredient | True | Pertuzumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
Australian dialect reference set
Description inactivation indicator reference set
FHIR